从临床经济学角度论胃手术后并发症的干预  

Clinical economics evaluation for intervention of complications after gastric surgery

作　　者：李子禹[1] 侯士阳 吴舟桥[1] 季加孚[1] Li Ziyu;Hou Shiyang;Wu Zhouqiao;Ji Jiafu.(Department of Gastrointestinal Cancer Center, Ward I, Key Laboratory of Carcinogenesis and Translational Research （Ministry of Education ）, Peking University Cancer Hospital ＆ Institute, Beijing 100142, China)

机构地区：[1]北京大学肿瘤医院暨北京市肿瘤防治研究所胃肠肿瘤中心一病区恶性肿瘤发病机制及转化研究教育部重点实验室,100142

出　　处：《中华消化外科杂志》2018年第6期555-559,共5页Chinese Journal of Digestive Surgery

基　　金：北京市科技计划课题（D141100000414004,Z151100004015070）;首都卫生发展科研专项（2014-1-2151）

摘　　要：胃肠道手术并发症日益成为国内外临床研究和实践过程中用以衡量手术安全性的重要指标。在实际临床决策过程中，除了以并发症机制作为干预切入点，并发症的临床经济学分析也是重要的参考依据。通过临床经济学分析，优化并发症诊断登记能够从国家宏观层面获得较高的投入产出比，并且通过微观分析，也能够进一步获得改善临床决策的着力点。通过对并发症干预措施的临床经济学分析，还能够更进一步理解胃外科术后并发症诸多干预措施在实践过程中的必要性、可行性，从而立足自身资源，优化临床策略，合理利用有限的卫生资源。Postoperative complications of gastrointesti- nal surgery have become an important indicator for evaluating surgical safety in the process of the domestic and foreign clinical research and practice. The clinical economics evaluation of the complications provides an important reference in the clinical decision-making process, in addition to the mechanism investi- gation. It reveals that higher cost-effectiveness can be obtained through optimizing complication diagnosis and registration process from a national macroscopic level, while it also uncovers the targets of the yet-to-be improved clinical decision making process in the microscopic analysis. Through clinical economics evaluation, the necessity and feasibility of interventions targeting the complications can be better understood the clinical practice, which would eventually optimize clinical strategies and proper use of the limited health resources.

关 键 词：胃肠道疾病 手术 并发症 卫生经济学 干预 

分 类 号：R656.6[医药卫生—外科学]